logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
K

Kim N.

university of british columbia

83H-index
842Paper Count
5.1WCitation Count
Published Papers 116
Publication Date
logo
Saruparib in combination with androgen receptor pathway inhibitors in metastatic hormone-sensitive prostate cancer: EvoPAR-Prostate01
errFuture Oncology
IF2.6
err2026-04-14
err0
PREAI
errArun A. Azad; Neeraj Agarwal; Andrew J. Armstrong; Eva Hellmis; Mikio Sugimoto; Yüksel Ürün; Nianzeng Xing; Mehreteab Aregay; Julianne Lima; Didier Meulendijks; Kim N. Chi
errShare
errSave
Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer
errNature Communications
IF15.7
err2025-12-17
err0
errOAAI
errSoumyajit Roy; Yilun Sun; Maha Hussain; Kim N. Chi; Karim Fizazi; Ian D. Davis; Susan Halabi; Neeraj Agarwal; Simon Chowdhury; Bertrand Tombal; Scott C. Morgan; Shawn Malone; Pedro C. Barata; Michael Ong; Christopher J. D. Wallis; Alejandro Berlin; Umang Swami; Amar U. Kishan; Angela Y. Jia; Nicholas G. Zaorsky; Jorge A. Garcia; Prateek Mendiratta; Jason R. Brown; Vinod V. Subhash; Martin R. Stockler; Hayley Thomas; Rana R. McKay; Eric J. Small; Neal D. Shore; Fred Saad; Christopher J. Sweeney; Daniel E. Spratt
errShare
errSave
Niraparib and abiraterone acetate plus prednisone for HRR-deficient metastatic castration-sensitive prostate cancer: a randomized phase 3 trial
errNature Medicine
IF50
err2025-10-07
err0
errOAAI
errGerhardt Attard; Neeraj Agarwal; Julie N. Graff; Shahneen Sandhu; Eleni Efstathiou; Mustafa Özgüroğlu; Andrea J. Pereira de Santana Gomes; Karina Vianna; Hong Luo; Geoffrey T. Gotto; Heather H. Cheng; Won Kim; Carly R. Varela; Daneen Schaeffer; Kassie Kramer; Susan Li; Benoit Baron; Fei Shen; Suneel D. Mundle; Sharon A. McCarthy; David Olmos; Kim N. Chi; Dana E. Rathkopf
errShare
errSave
Cabazitaxel Versus Abiraterone or Enzalutamide for Poor-prognosis Metastatic Castration-resistant Prostate Cancer After Docetaxel: A Phase 2 Trial with a Circulating Tumor DNA Analysis
errEuropean Urology Oncology
IF9.3
err2025-09-30
err0
errOAAI
errKaran Parekh; Kim van der Zande; Sarah W.S. Ng; Cameron Herberts; Edmond M. Kwan; Gillian Vandekerkhove; Vincent van der Noort; Milou P.H. Busard; Aart Beeker; Pieter van den Berg; Jeantine M. de Feijter; Vincent Dezentje; Paul Hamberg; Danny Houtsma; Suzan Ras; Metin Tascilar; Rebecca D. Tutuhatunewa-Louhanepessy; Yi Jou (Ruby) Liao; Sofie H. Tolmeijer; Gráinne Donnellan; Kim N. Chi; Alexander W. Wyatt; Wilbert Zwart; Andries M. Bergman
errShare
errSave
Apalutamide in Patients with High Burden of Metastatic Hormone-sensitive Prostate Cancer: A Subgroup Analysis of TITAN
errEuropean Urology Oncology
IF9.3
err2025-09-29
err0
errOAAI
errAlejo Rodriguez-Vida; Angel Borque; Fernando Lopez-Campos; Alvaro Juarez Soto; Beatriz Garcillan; Cristian Vidal; Joana Lencart; Amitabha Bhaumik; Suneel D. Mundle; Suzy Van Sanden; Kim N. Chi; Anders Bjartell; Neeraj Agarwal; Axel S. Merseburger
errShare
errSave
Health-related quality of life, pain, and symptomatic skeletal events with [177Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): an open-label, randomised, phase 3 trial
errlancet oncology
IF0
err2025-05-26
err0
PREAI
errKarim Fizazi; Michael J Morris; Neal D Shore; Kim N Chi; Michael Crosby; Johann S de Bono; Ken Herrmann; Guilhem Roubaud; James Nagarajah; Mark Fleming; Brian Lewis; Luke Nordquist; Natalie Carnahan; Samson Ghebremariam; Marianna Hertelendi; Daniel Castellano; Oliver Sartor
errShare
errSave
Niraparib and Abiraterone Acetate plus Prednisone in Metastatic Castration-resistant Prostate Cancer: Final Overall Survival Analysis for the Phase 3 MAGNITUDE Trial
errEuropean Urology Oncology
IF9.3
err2025-05-05
err0
errOAAI
errKim N. Chi; Elena Castro; Gert Attard; Matthew R. Smith; Shahneen Sandhu; Eleni Efstathiou; Guilhem Roubaud; Eric J. Small; Andrea Pereira de Santana Gomes; Dana E. Rathkopf; Marniza Saad; Howard Gurney; Wonho Jung; Won Kim; Shiva Dibaj; Daphne Wu; Jenny Zhang; Angela Lopez-Gitlitz; Peter Francis; David Olmos
errShare
errSave
A plain language summary of the results from the MAGNITUDE study assessing how effective and how safe niraparib and abiraterone acetate with prednisone is in patients with metastatic castration-resistant prostate cancer
errFUTURE ONCOLOGY
IF2.6
err2025-03-01
err0
errOAAI
errChi, Kim N.; Rathkopf, Dana; Smith, Matthew R.; Efstathiou, Eleni; Attard, Gerhardt; Olmos, David; Lee, Ji Youl; Small, Eric J.; Gomes, Andrea J. Pereira de Santana; Roubaud, Guilhem; Saad, Marniza; Zurawski, Bogdan; Sakalo, Valerii; Mason, Gary E.; Francis, Peter; Wang, George; Wu, Daphne; Diorio, Brooke; Lopez-Gitlitz, Angela; Sandhu, Shahneen
errShare
errSave
Initial clinical experience with [177Lu]Lu-PNT2002 radioligand therapy in metastatic castration-resistant prostate cancer: dosimetry, safety, and efficacy from the lead-in cohort of the SPLASH trial
errFRONTIERS IN ONCOLOGY
IF3.3
err2025-01-07
err0
errOAAI
errHansen, Aaron R.; Probst, Stephan; Beauregard, Jean-Mathieu; Viglianti, Benjamin L.; Michalski, Jeff M.; Tagawa, Scott T.; Sartor, Oliver; Tutrone, Ronald F.; Oz, Orhan K.; Courtney, Kevin D.; Delpassand, Ebrahim S.; Nordquist, Luke T.; Osman, Medhat M.; Chi, Kim N.; Sparks, Richard; George, Noble; Hawley, Sara M.; Wu, Wenting; Jensen, Jessica D.; Fleshner, Neil E.
errShare
errSave
Multivariable models of outcomes with [177Lu]Lu-PSMA-617: analysis of the phase 3 VISION trial
errECLINICALMEDICINE
IF10
err2024-11-01
err0
errOAAI
errHerrmann, Ken; Gafita, Andrei; de Bono, Johann S.; Sartor, Oliver; Chi, Kim N.; Krause, Bernd J.; Rahbar, Kambiz; Tagawa, Scott T.; Czernin, Johannes; El-Haddad, Ghassan; Wong, Connie C.; Zhang, Zhaojie; Wilke, Celine; Mirante, Osvaldo; Morris, Michael J.; Fizazi, Karim
errShare
errSave
Patient-reported Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer and BRCA1/2 Gene Alterations: Final Analysis from the Randomized Phase 3 MAGNITUDE Trial
errEuropean Urology
IF25.2
err2024-09-23
err0
errOAAI
errDana E. Rathkopf; Guilhem Roubaud; Kim N. Chi; Eleni Efstathiou; Gerhardt Attard; David Olmos; Eric J. Small; Marniza Saad; Elena Castro; Won Kim; Daphne Wu; Kristi Bertzos; Shiva Dibaj; Jenny Zhang; Peter Francis; Matthew R. Smith
errShare
errSave
177Lu-PSMA-617 versus a change of androgen receptor pathway inhibitor therapy for taxane-naive patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): a phase 3, randomised, controlled trial
errLANCET
IF88.5
err2024-09-01
err4
PREAI
errMorris, Michael J.; Castellano, Daniel; Herrmann, Ken; de Bono, Johann S.; Shore, Neal D.; Chi, Kim N.; Crosby, Michael; Piulats, Josep M.; Flechon, Aude; Wei, Xiao X.; Mahammedi, Hakim; Roubaud, Guilhem; Studentova, Hana; Nagarajah, James; Mellado, Begona; Montesa-Pino, Alvaro; Kpamegan, Euloge; Ghebremariam, Samson; Kreisl, Teri N.; Wilke, Celine; Lehnhoff, Katja; Sartor, Oliver; Fizazi, Karim
errShare
errSave
Prostate-specific antigen and health-related quality of life in individuals with advanced prostate cancer treated with apalutamide: a plain language summary of the SPARTAN and TITAN studies
errFUTURE ONCOLOGY
IF2.6
err2024-08-20
err0
errOAAI
errKarsh, Lawrence I.; Bevans, Katherine B.; Saad, Fred; Chung, Byung Ha; Oudard, Stephane; Brookman-May, Sabine D.; Mccarthy, Sharon A.; Smith, Matthew R.; Chi, Kim N.; Small, Eric J.; Agarwal, Neeraj
errShare
errSave
Post Hoc Analysis of Rapid and Deep Prostate-specific Antigen Decline and Patient-reported Health-related Quality of Life in SPARTAN and TITAN Patients with Advanced Prostate Cancer
errEUROPEAN UROLOGY ONCOLOGY
IF9.3
err2024-08-01
err5
PREAI
errSmall, Eric J.; Chi, Kim N.; Chowdhury, Simon; Bevans, Katherine B.; Bhaumik, Amitabha; Saad, Fred; Ha Chung, Byung; Karsh, Lawrence I.; Oudard, Stephane; De Porre, Peter; Brookman-May, Sabine D.; McCarthy, Sharon A.; Mundle, Suneel D.; Uemura, Hirotsugu; Smith, Matthew R.; Agarwal, Neeraj
errShare
errSave
Early Prostate-Specific Antigen Response by 6 Months Is Predictive of Treatment Effect in Metastatic Hormone Sensitive Prostate Cancer: An Exploratory Analysis of the TITAN Trial
errJOURNAL OF UROLOGY
IF6.8
err2024-07-26
err1
PREAI
errRoy, Soumyajit; Sun, Yilun; Chi, Kim N.; Ong, Michael; Malone, Shawn; Wallis, Christopher J. D.; Kishan, Amar U.; Malone, Julia; Swami, Umang; Gebrael, Georges; Brown, Jason R.; Jia, Angela Y.; Morgan, Scott C.; Saad, Fred; Chowdhury, Simon; Agarwal, Neeraj; Spratt, Daniel E.
errShare
errSave
Correlation analyses of radiographic progression-free survival with clinical and health-related quality of life outcomes in metastatic castration-resistant prostate cancer: Analysis of the phase 3 VISION trial
errCANCER
IF5.1
err2024-06-21
err1
errOAAI
errMorris, Michael J.; de Bono, Johann; Nagarajah, James; Sartor, Oliver; Wei, Xiao X.; Nordquist, Luke T.; Koshkin, Vadim S.; Chi, Kim N.; Krause, Bernd J.; Herrmann, Ken; Rahbar, Kambiz; Vickers, Adrian; Mirante, Osvaldo; Ghouse, Ray; Fizazi, Karim; Tagawa, Scott T.
errShare
errSave
Safety Analyses of the Phase 3 VISION Trial of [ 177 Lu]Lu-PSMA-617 in Patients with Metastatic Castration-resistant Prostate Cancer
errEUROPEAN UROLOGY
IF25.2
err2024-04-01
err5
errOAAI
errChi, Kim N.; Armstrong, Andrew J.; Krause, Bernd J.; Herrmann, Ken; Rahbar, Kambiz; de Bono, Johann S.; Adra, Nabil; Garje, Rohan; Michalski, Jeff M.; Kempel, Mette M.; Fizazi, Karim; Morris, Michael J.; Sartor, Oliver; Brackman, Marcia; Desilvio, Michelle; Wilke, Celine; Holder, Geoffrey; Tagawa, Scott T.
errShare
errSave
Effect of Prior Prostate Directed Local Therapy on Response to Apalutamide in Metastatic Hormone Sensitive Prostate Cancer: A Secondary Analysis of the TITAN Study
errEUROPEAN UROLOGY
IF25.2
err2024-04-01
err1
PREAI
errRoy, Soumyajit; Saad, Fred; Malone, Shawn; Agarwal, Neeraj; Mohamad, Osama; Morgan, Scott C.; Malone, Julia; Swami, Umang; Jia, Angela Y.; Gebrael, Georges; Mendiratta, Prateek; Brown, Jason R.; Rao, Santosh K.; Sun, Yilun; Wallis, Christopher J. D.; Chi, Kim N.; Chowdhury, Simon; Kishan, Amar U.; Spratt, Daniel E.
errShare
errSave
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer
errNATURE COMMUNICATIONS
IF15.7
err2024-02-28
err13
errOAAI
errFonseca, Nicolette M.; Maurice-Dror, Corinne; Herberts, Cameron; Tu, Wilson; Fan, William; Murtha, Andrew J.; Kollmannsberger, Catarina; Kwan, Edmond M.; Parekh, Karan; Schonlau, Elena; Bernales, Cecily Q.; Donnellan, Grainne; Ng, Sarah W. S.; Sumiyoshi, Takayuki; Vergidis, Joanna; Noonan, Krista; Finch, Daygen L.; Zulfiqar, Muhammad; Miller, Stacy; Parimi, Sunil; Lavoie, Jean-Michel; Hardy, Edward; Soleimani, Maryam; Nappi, Lucia; Eigl, Bernhard J.; Kollmannsberger, Christian; Taavitsainen, Sinja; Nykter, Matti; Tolmeijer, Sofie H.; Boerrigter, Emmy; Mehra, Niven; van Erp, Nielka P.; De Laere, Bram; Lindberg, Johan; Gronberg, Henrik; Khalaf, Daniel J.; Annala, Matti; Chi, Kim N.; Wyatt, Alexander W.
errShare
errSave
Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer
errCANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
IF3.4
err2024-01-08
err1
errOAAI
errChen, Naiyu; Mcgrath, Colleen B.; Ericsson, Caroline I.; Vaselkiv, Jane B.; Rencsok, Emily M.; Stopsack, Konrad H.; Guard, Hannah E.; Autio, Karen A.; Rathkopf, Dana E.; Enting, Deborah; Bitting, Rhonda L.; Mateo, Joaquin; Githiaka, Charles W.; Chi, Kim N.; Cheng, Heather H.; Davis, Ian D.; Anderson, Simon G.; Badal, Simone Ann Marie; Bjartell, Anders; Russnes, Kjell M.; Heath, Elisabeth I.; Pomerantz, Mark M.; Henegan, John C.; Hyslop, Terry; Esteban, Emilio; Omlin, Aurelius; Mcdermott, Ray; Fay, Andre P.; Popoola, Ademola Alabi; Ragin, Camille; Nowak, Joel; Gerke, Travis; Kantoff, Philip W.; George, Daniel J.; Penney, Kathryn L.; Mucci, Lorelei A.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
S
Steven J.M. Jones
H-index: 189 · Papers: 1.3K
M
Mark A. Rubin
H-index: 186 · Papers: 1.5K
H
Howard I. Scher
H-index: 164 · Papers: 1.4K
C
Chuan He
H-index: 161 · Papers: 978
J
Johann S. de Bono
H-index: 160 · Papers: 2.5K
View more